Verapamil treatment after coronary angioplasty in patients at high risk of recurrent stenosis.

OBJECTIVE--To evaluate the efficacy of high-dose verapamil treatment (240 mg twice daily) in the prevention of angiographic restenosis after primary successful coronary angioplasty in patients at high risk of recurrent obstruction. DESIGN--A placebo controlled, double blind trial in which patients w...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Hoberg, E., Dietz, R., Frees, U., Katus, H. A., Rauch, B., Schömig, A., Schuler, G., Schwarz, F., Tillmanns, H., Niebauer, J.
Format: Artigo
Langue:Inglês
Publié: 1994
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC483663/
https://ncbi.nlm.nih.gov/pubmed/8142195
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires